Clinical Trial Update: Antineoplaston Therapy in Treating Patients With Stage IV Melanoma [Phase 2]

View source ↗

Summary

Phase 2 trial of antineoplaston therapy in patients with Stage IV melanoma has been terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Antineoplaston therapy

Snippet

Sponsor: Burzynski Research Institute | Conditions: Stage IV Melanoma | Phase 2 | Status: TERMINATED | Results posted: 2020-12-19